Description

SHORT DESCRIPTION:

Biograil, founded in 2019 and led by CEO Karsten Lindhardt, is using injection molding to manufacture a device contained in a standard size capsule able to deliver active substances into the gastrointestinal wall. The Biograil device avoids mechanical moving components and makes use of the body own peristaltic forces to facilitate the delivery of the biologic efficiently into the gastrointestinal wall.

 

LONG DESCRIPTION:

Based in

Copenhagen

Nation
Founded in

2019

Founding Status

$ 2.5 Millions - $ 5 Millions

mood_bad
  • No comments yet.
  • Add a review
      error: Content protected